RSS Anyway
Sign in
RSS Anyway
Hot
Latest
Following
Status
About
Sign in
RSS Anyway
Hot
Latest
Following
Status
About
statnews.com
Sign in to follow
statnews.com
RSS
Atom
JSON
items
|
feeds
31.
Opinion: What should hospitals do when patients demand unvaccinated donor blood?
statnews.com
·
/feed
▲ 0
· Jun 1
32.
STAT+: A turning point for pancreatic cancer patients
statnews.com
·
/feed
▲ 0
· Jun 1
33.
CDC says containing the spread of Ebola is top priority
statnews.com
·
/feed
▲ 0
· Jun 1
34.
STAT+: Servier to buy Edgewise Therapeutics’ muscular dystrophy drug
statnews.com
·
/feed
▲ 0
· Jun 1
35.
STAT+: No Surprises Act arbitration rule could worsen flood of provider disputes
statnews.com
·
/feed
▲ 0
· Jun 1
36.
The hidden history of BPC-157, a favorite MAHA peptide
statnews.com
·
/feed
▲ 0
· Jun 1
37.
STAT+: Medicare still won’t say how much covering obesity drugs will cost
statnews.com
·
/feed
▲ 0
· Jun 1
38.
STAT+: Executives reveal tech initiatives at Summa Health, eight months after General Catalyst acquisition
statnews.com
·
/feed
▲ 0
· Jun 1
39.
Opinion: Medical schools diversified. So where are all the diverse doctors?
statnews.com
·
/feed
▲ 0
· Jun 1
40.
Opinion: The military’s medical corps has a serious recruitment problem
statnews.com
·
/feed
▲ 0
· Jun 1
41.
STAT+: A standing ovation for RevMed, and caution for Akeso
statnews.com
·
/feed
▲ 0
· May 31
42.
Ultra-low doses could bring costly cancer treatments to more patients in poorer countries
statnews.com
·
/feed
▲ 0
· May 31
43.
STAT+: Akeso and Summit’s ivonescimab extends survival in squamous cell lung cancer
statnews.com
·
/feed
▲ 0
· May 31
44.
STAT+: Practice-changing results reported for Revolution Medicines pancreatic cancer drug
statnews.com
·
/feed
▲ 0
· May 31
45.
STAT+: For prostate cancer patients set on surgery, new hormone regimen may improve outcomes, study finds
statnews.com
·
/feed
▲ 0
· May 31
46.
STAT+: BioNTech and Pfizer tout bispecifics data at ASCO, and Pazdur sees silver lining at FDA
statnews.com
·
/feed
▲ 0
· May 30
47.
STAT+: China competition, ‘destruction’ at FDA give agency chance to restructure, Rick Pazdur says
statnews.com
·
/feed
▲ 0
· May 30
48.
STAT+: Revolution Medicines starts shipping experimental pancreatic cancer drug
statnews.com
·
/feed
▲ 0
· May 30
49.
STAT+: As Ebola outbreak grows, Trump administration veers from previous government playbook
statnews.com
·
/feed
▲ 0
· May 30
50.
STAT+: At ASCO, positive data for Bristol in multiple myeloma and Pfizer in lung cancer
statnews.com
·
/feed
▲ 0
· May 29
51.
STAT+: Trump administration seeks to overhaul federal grantmaking process, alarming researchers
statnews.com
·
/feed
▲ 0
· May 29
52.
Kenya court suspends U.S. plan for Ebola quarantine facility for Americans
statnews.com
·
/feed
▲ 0
· May 29
53.
STAT+: Pharmalittle: We’re reading about Replimune drug getting third try at FDA approval, a Pfizer deal in China, and more
statnews.com
·
/feed
▲ 0
· May 29
54.
STAT+: Allogene CEO David Chang stepping down
statnews.com
·
/feed
▲ 0
· May 29
55.
STAT+: Massachusetts sues UnitedHealth, alleging fraud in state’s Medicaid plans for seniors
statnews.com
·
/feed
▲ 0
· May 29
56.
Which vaccines will curb the Ebola outbreak? WHO debates
statnews.com
·
/feed
▲ 0
· May 29
57.
STAT+: Up and down the ladder: The latest comings and goings
statnews.com
·
/feed
▲ 0
· May 29
58.
Opinion: I’m a weight-loss doctor. Here’s why I worry about GLP-1 ‘microdoses’
statnews.com
·
/feed
▲ 0
· May 29
59.
STAT+: The woman behind the world’s biggest longevity competition
statnews.com
·
/feed
▲ 0
· May 29
60.
STAT+: As Ebola outbreak in Central Africa grows, the U.S. turns itself into a fortress
statnews.com
·
/feed
▲ 0
· May 28
← prev
page 2
next →